← Human Trials & Peer-Reviewed Studies
Effects of Increased Frequency, High Dose, and Pulsatile Oxytocin Regimens on Abnormal Labor Delivery
Plain-language guide to PMID 29626416 (2018): randomized controlled trial study of Oxytocin in 900 women.
Key Facts
- PMID
- 29626416
- Journal
- Medical science monitor : international medical journal of experimental and clinical research
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Liu J et al. (3 authors)
- DOI
- 10.12659/msm.906728
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Oxytocin, published as a randomized controlled trial.
The objective of the present study was to compare effects and safety measures of various available regimens of oxytocin in abnormal labor delivery.
Why It Was Studied
BACKGROUND The current guideline for oxytocin regimens in the abnormal labor of delivery is continuous infusion.
Pregnant women received oxytocin as continuous administration of 16 mU/min (Group I), 1 mU/min (group II), 4 mU/min (group III), 5 mU/min quarter-hourly (group IV), and through a syringe pump (group V).
Who Took Part
The study group was 900 women.
The age groups tagged for this paper are adults, women only.
MATERIAL AND METHODS In this clinical experimental study, a total of 900 pregnant women admitted for delivery were randomized into 5 group with 162 each.
How the Study Was Run
In design terms this was a randomized study.
The women were allocated by chance, so the Oxytocin group and the comparison group should start out alike.
What Was Measured
Measurement of the expense of delivery, the ratio of the instrumental delivery, and the other secondary outcome measures was performed to find the best regimen of oxytocin.
PubMed files the paper under topics including Delivery, Obstetric, Dystocia, Infusion Pumps, Labor, Obstetric and Oxytocin.
What This Means in Plain Language
The paper is a randomized study of Oxytocin in 900 women.
With several hundred people or more, it is a fairly large study for this kind of research.
The publication is from 2018 (Medical science monitor : international medical journal of experimental and clinical research), a journal based in United States.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.